Co-GP / Platform:A family office could deploy into the life sciences market by partnering with a reputable operator to co-GP on lab space developments, leveraging their expertise and access to a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level, focusing on those with a strong track record in navigating market fluctuations.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a robust pipeline.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor/operator at the GP level, sharing in the promote and aligning interests to capitalize on future recovery.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a robust pipeline.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on projects that can capitalize on the current high vacancy and funding landscape.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level to capitalize on the growing need for innovative life sciences spaces.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator at the GP level to capitalize on the reduced vacancy and limited available space.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, focusing on those with a strong track record in managing vacancies.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and accessing a pipeline of distressed assets.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of new lab developments.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to align interests and access a robust pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, sharing in the promote and benefiting from their industry knowledge.

Co-GP / Platform:A family office could deploy into the Houston life sciences market by backing a sponsor/operator focused on biopharmaceutical manufacturing to share in the promote and benefit from the sector's growth.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor with a proven track record in managing lab assets, particularly in high-demand areas like San Diego and San Francisco.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a specialized operator at the GP level, focusing on co-GP or JV equity to capitalize on the sector's growth.

Co-GP / Platform:A family office could deploy into the Puget Sound life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level to capitalize on the evolving leasing landscape.